丙氨酸布立尼布是一种ATP竞争性的 VEGFR2 抑制剂,IC50 值为 25 nM;可以适度抑制 VEGFR1 和 FGFR1,对 VEGFR2 的选择性是对 PDGFRβ的 240 倍,是一种用于口服给药的研究性抗肿瘤药物,用于治疗肝细胞癌或肝癌(也称为恶性肝癌),最常见的肝癌。
-
默认
常备现货
-
纯度
- 请选择
- 99+%
- 99%
- 98+%
- 98%
- 97+%
- 97%
- 96+%
- 96%
- 95+%
- 95%
- 93%
- 90+%
- 90%
规格
- 请选择
- 1mg
- 2mg
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 1g
- 5g
- 10g
- 25g
- 100g
- 500g
- 1000g
- 1kg
清空选项
-
(R)-1-((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2-ol
-
BD208781649735-46-696%
-
¥897.0050mg常备现货
-
Ethyl 2-((dimethylamino)methylene)-3-oxobutanoate
-
BD2111651145-57-495%
-
¥527.00100g常备现货
-
1-(2-Fluoro-3-methoxy-6-nitrophenyl)propan-2-one
-
BD262292288385-99-997%
-
¥253.00250mg常备现货
-
1-(2,3-Difluoro-6-nitrophenyl)propan-2-one
-
BD83575121247-16-398%
-
¥7199.001g
-
6-(Benzyloxy)-4-chloro-5-methylpyrrolo[2,1-f][1,2,4]triazine
-
BD334920649736-27-698+%
-
¥12461.001g
-
6-(Benzyloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-4(3H)-one
-
BD301883649736-26-595+%
-
¥5782.001g
-
4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol
-
BD246225649735-41-195+%
-
¥6000.00100mg
-
Ethyl 4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxylate
-
BD246226649736-29-895+%
-
¥5794.001g
-
2-(4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)propan-2-ol
-
BD246227649736-30-195+%
-
¥9017.001g